N/A
Completed N=54
Transitional Rehabilitation in CABG Patients
Coronary Artery Disease · Coronary Artery Bypass Graft Surgery
Source: ClinicalTrials.gov NCT03892460 ↗
Enrolled (actual)
54
Serious AEs
0.0%
Results posted
Aug 2021
Primary outcomePrimary: Short Physical Performance Battery — 7.33; 8.00; 11.44; 10.90 units on a scale
Summary
The goal of this research study is to understand whether an at-home exercise program started soon after CABG surgery, and continuing for 4 weeks following discharge from the hospital, can preserve or improve physical function.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Short Physical Performance Battery |
7.33; 8.00; 11.44; 10.90 | — |
| SECONDARY 6 Minute Walk Distance |
216; 238; 482; 431 | — |
| SECONDARY Medical Outcomes Short Form 36 - Physical Function |
40; 33; 70; 58 | — |
| SECONDARY Medical Outcome Short Form 36 - Role Physical |
26; 21; 19; 18 | — |
| SECONDARY Medical Outcomes Short Form 36 - Bodily Pain |
31; 28; 28; 27 | — |
| SECONDARY Medical Outcomes Short Form 36 - General Health |
71; 63; 81; 72 | — |
| SECONDARY Medical Outcomes Short Form 36 - Vitality |
55; 53; 55; 51 | — |
| SECONDARY Medical Outcomes Short Form 36 - Social Function |
74; 63; 76; 72 | — |
| SECONDARY Medical Outcomes Short Form 36 - Role Emotional |
65; 54; 72; 51 | — |
| SECONDARY Medical Outcomes Short Form 36 |
77; 74; 86; 78 | — |
| SECONDARY Physical Activity |
125.6; 109.6 | — |
Eligibility Criteria
Inclusion Criteria
- 50-80 yrs of age
- ambulatory
- scheduled for coronary artery bypass graft surgery
- able to provide informed consent
Exclusion Criteria
- rheumatoid arthritis or other inflammatory/autoimmune disease
- cancer, excluding non-melanoma skin cancer
- exercise limiting peripheral vascular disease
- neuromuscular disease or neuromuscular dysfunction associated with cerebrovascular event
- body mass index >38 kg/m2
- valvular heart disease not corrected surgically
- lower extremity blood clot or implantable cardioverter-defibrillator
Data sourced from ClinicalTrials.gov (NCT03892460). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.